Oza, Amit, Cook, Adrian D, Pfisterer, Jacobus, Embleton, Andrew, Ledermann, Jonathan A., Pujade-lauraine, Eric, Kristensen, Gunnar, Carey, Mark S, Beale, Philip, Cervantes, Andrés, Park-Simon, Tjoung-Won, Rustin, Gordon Js, Joly, F, Mirza, Mansoor R., Plante, Marie, Quinn, Michael, Poveda, Andres, Jayson, Gordon C, Stark, Dan, Swart, Ann Marie ORCID: https://orcid.org/0000-0002-9359-6995, Farrelly, Laura, Kaplan, Richard S, Parmar, Mahesh K.b. and Perren, Timothy J. (2015) Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. The Lancet Oncology, 16 (8). 928–936. ISSN 1470-2045
Preview |
PDF (ICON7 OS results Lancet 2015)
- Published Version
Available under License Creative Commons Attribution. Download (415kB) | Preview |
Item Type: | Article |
---|---|
Uncontrolled Keywords: | sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) |
Depositing User: | Pure Connector |
Date Deposited: | 24 Jul 2015 23:03 |
Last Modified: | 21 Oct 2022 01:02 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/53798 |
DOI: | 10.1016/S1470-2045(15)00086-8 |
Downloads
Downloads per month over past year
Actions (login required)
View Item |